PHA ACE2 soluble ace2
(Unterschied zwischen Versionen)
Ossip Groth (Diskussion | Beiträge)
(Die Seite wurde neu angelegt: „{{up|Target ACE2, Spike protein}} {{tp|p=32391299|t=2020. COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children.|pdf=|usr=008}…“)
Zum nächsten Versionsunterschied →
(Die Seite wurde neu angelegt: „{{up|Target ACE2, Spike protein}} {{tp|p=32391299|t=2020. COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children.|pdf=|usr=008}…“)
Zum nächsten Versionsunterschied →
Version vom 27. April 2021, 17:24 Uhr
| Target ACE2, Spike protein |
32391299 2020. COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children.
32410690 2020. Age and sex differences in soluble ACE2 may give insights for COVID-19.
32396773 2020. Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent.
32333836 ä. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
32398309 2020. Could the smoking gun in the fight against Covid-19 be the (rh) ACE2?
32438383 2020. Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection.
